Long noncoding RNA H19 mediated the chemosensitivity of breast cancer cells via Wnt pathway and EMT process

References

• BartschRBergenEASCO 2017: highlights in breast cancerMemo201710422823229250202
   PubMedGoogle Scholar
• AgarwalaVChoudharyNGuptaSA risk-benefit assessment approach to selection of adjuvant chemotherapy in elderly patients with early breast cancer: a mini reviewIndian J Med Paediatr Oncol201738452653429333024
   PubMed Web of Science ®Google Scholar
• BaşaranGATwelvesCDiérasVCortésJAwadaAOngoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancerCancer Treat Rev20186314415529329006
   PubMed Web of Science ®Google Scholar
• CalhounBCCollinsLCPredictive markers in breast cancer: an update on ER and HER2 testing and reportingSemin Diagn Pathol201532536236925770732
   PubMed Web of Science ®Google Scholar
• LeeADjamgozMBATriple negative breast cancer: emerging therapeutic modalities and novel combination therapiesCancer Treat Rev20186211012229202431
   PubMed Web of Science ®Google Scholar
• WuYZhangZCenciariniMETamoxifen resistance in breast cancer is regulated by the EZH2-ERα-GREB1 transcriptional axisCancer Res201878367168429212856
   PubMed Web of Science ®Google Scholar
• HuangXLuoYLMaoYSJiJLJlJThe link between long noncoding RNAs and depressionProg Neuropsychopharmacol Biol Psychiatry201773737827318257
   PubMed Web of Science ®Google Scholar
• MirzaAHKaurSPociotFLong non-coding RNAs as novel players in β cell function and type 1 diabetesHum Genomics20171111728738846
   PubMed Web of Science ®Google Scholar
• LuoQChenYLong noncoding RNAs and Alzheimer’s diseaseClin Interv Aging20161186787227418812
   PubMed Web of Science ®Google Scholar
• ColletteJLe BourhisXAdriaenssensERegulation of human breast cancer by the long non-coding RNA H19Int J Mol Sci201718112319
   PubMed Web of Science ®Google Scholar
• HuPYangJHouYLncRNA expression signatures of twist-induced epithelial-to-mesenchymal transition in MCF10A cellsCell Signal2014261839324113349
   PubMed Web of Science ®Google Scholar
• LiangWCFuWMWangYBH19 activates Wnt signaling and promotes osteoblast differentiation by functioning as a competing endogenous RNASci Rep201662012126853553
   PubMed Web of Science ®Google Scholar
• WuKFLiangWCFengLH19 mediates methotrexate resistance in colorectal cancer through activating Wnt/β-catenin pathwayExp Cell Res2017350231231727919747
   PubMed Web of Science ®Google Scholar
• ChenJWangTZhouYCAquaporin 3 promotes epithelial-mesenchymal transition in gastric cancerJ Exp Clin Cancer Res2014333824887009
   PubMed Web of Science ®Google Scholar
• ZhouWYeXLXuJThe lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7bSci Signal201710483eaak955728611183
   PubMed Web of Science ®Google Scholar
• LiTMoXFuLXiaoBGuoJMolecular mechanisms of long non-coding RNAs on gastric cancerOncotarget2016788601861226788991
   PubMedGoogle Scholar
• FedelePCiccareseMSuricoGCinieriSAn update on first line therapies for metastatic breast cancerExpert Opin Pharmacother201819324325229336185
   PubMed Web of Science ®Google Scholar
• Gonzalez-AnguloAMMorales-VasquezFHortobagyiGNOverview of resistance to systemic therapy in patients with breast cancerAdv Exp Med Biol200760812217993229
   PubMed Web of Science ®Google Scholar
• LiCXLiHGHuangLTH19 lncRNA regulates keratinocyte differentiation by targeting miR-130b-3pCell Death Dis2017811e317429192645
   PubMed Web of Science ®Google Scholar
• WeiYLiuZFangJH19 functions as a competing endogenous RNA to regulate human epidermal growth factor receptor expression by sequestering let-7c in gastric cancerMol Med Rep20181722600260629207111
   PubMed Web of Science ®Google Scholar
• SiXZangRZhangELncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIKOncotarget2016749814528146227845892
   PubMedGoogle Scholar
• YuMBardiaAWittnerBSCirculating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal compositionScience2013339611958058423372014
   PubMed Web of Science ®Google Scholar
• GunasingheNPWellsAThompsonEWHugoHJMesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancerCancer Metastasis Rev2012313–446947822729277
   PubMed Web of Science ®Google Scholar
• LottinSAdriaenssensEDupressoirTOverexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cellsCarcinogenesis200223111885189512419837
   PubMed Web of Science ®Google Scholar
• OhanaPKopfEBibiOThe expression of the H19 gene and its function in human bladder carcinoma cell linesFEBS Lett19994541–2818410413100
   PubMed Web of Science ®Google Scholar
• LuoMLiZWangWZengYLiuZQiuJLong non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expressionCancer Lett2013333221322123354591
   PubMed Web of Science ®Google Scholar
• MatoukIJRavehEAbu-LailROncofetal H19 RNA promotes tumor metastasisBiochim Biophys Acta2014184371414142624703882
   PubMed Web of Science ®Google Scholar
• RingADowsettMMechanisms of tamoxifen resistanceEndocr Relat Cancer200411464365815613444
   PubMed Web of Science ®Google Scholar
• YamaguchiNNakayamaYYamaguchiNDown-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6J Biol Chem2017292208136814828270510
   PubMed Web of Science ®Google Scholar
• ChenSYaoFXiaoQEZH2 inhibition sensitizes tamoxifen- resistant breast cancer cells through cell cycle regulationMol Med Rep20181722642265029207119
   PubMed Web of Science ®Google Scholar
• SainiKSLoiSde AzambujaETargeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancerCancer Treat Rev201339893594623643661
   PubMed Web of Science ®Google Scholar
• Herter-SprieGSGreulichHWongKKActivating mutations in ERBB2 and their impact on diagnostics and treatmentFront Oncol201338623630663
   PubMedGoogle Scholar